CÔNG TY CỔ PHẦN DƯỢC PHẨM MEDBOLIDE

FLIBGA REPORT - EFFECTIVE SOLUTIONS IN TREATMENT OF ACUTE AND SEVERE VESTIBUSTICIAL DISORDERS AT DUC KHANG HOSPITAL

With the criteria of bringing many solutions to patients, Medbolide is always diverse in research and creates many treatment products for all types of diseases to meet the needs of hospitals in general and patients in particular.

On June 8, 2023, Medbolide Joint Stock Company had the opportunity to work and discuss directly with the Director of CKII Hospital Ton That Quynh Ai and all Doctors, Pharmacists and Nurses at Duc Khang Hospital with various specialties. Medical examination – Emergency; Department of Internal Medicine - Dialysis Unit, Department of Surgery - Anesthesiology - Oncology Unit and paraclinical department. During the seminar, Medbolide brought EFFECTIVE SOLUTIONS IN THE TREATMENT OF ACUTE AND SEVERE VESTIBULAR DISORDER with FLIBGA PRODUCT, active ingredient Meclizine:

Effectiveness equivalent to Diazepam; Active ingredients have been approved by the FDA since 1957; First choice in the treatment of severe vestibular disorders; Reduces dizziness and nausea in the first 7 days of vestibular disorders.

Medbolide – Creating quality pills, bringing good treatment results, contributing to the health care of Vietnamese people.

Pic 1
Pic 2
Pic 3
Pic 4
Readers comments